On December 2, according to Gelonghui, Yabao Pharmaceutical Group (600351.SH) announced that as of November 30, 2024, the company has repurchased a total of 5,419,097 shares through centralized bidding, accounting for 0.75% of the company's total share capital. The highest fill price for the repurchase was 6.56 yuan/share, the lowest fill price was 5.87 yuan/share, and the total amount paid was 33,948,400.49 yuan (excluding transaction fees).
亚宝药业(600351.SH)：已累计回购0.75%股份
Yabao Pharmaceutical Group (600351.SH): has repurchased a total of 0.75% of its shares.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated